402 related articles for article (PubMed ID: 18842377)
1. Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
Krishnan-Natesan S; Chandrasekar PH; Manavathu EK; Revankar SG
Diagn Microbiol Infect Dis; 2008 Dec; 62(4):443-6. PubMed ID: 18842377
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole -- better chances for patients with invasive mycoses.
Ghannoum MA; Kuhn DM
Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
[TBL] [Abstract][Full Text] [Related]
3. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
[TBL] [Abstract][Full Text] [Related]
4. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.
Azzola A; Passweg JR; Habicht JM; Bubendorf L; Tamm M; Gratwohl A; Eich G
J Clin Microbiol; 2004 Oct; 42(10):4805-8. PubMed ID: 15472346
[TBL] [Abstract][Full Text] [Related]
5. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
[TBL] [Abstract][Full Text] [Related]
6. Successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Ford JG; Agee S; Greenhaw ST
Cornea; 2008 Oct; 27(9):1077-9. PubMed ID: 18812777
[TBL] [Abstract][Full Text] [Related]
7. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
[TBL] [Abstract][Full Text] [Related]
8. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Klein KC; Blackwood RA
Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
Takemoto K; Yamamoto Y; Ueda Y; Kanazawa K; Yoshida K; Niki Y
Chemotherapy; 2009; 55(2):105-13. PubMed ID: 19151551
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of current drug therapies for invasive aspergillosis.
Traunmüller F; Popovic M; Konz KH; Smolle-Jüttner FM; Joukhadar C
Pharmacology; 2011; 88(3-4):213-24. PubMed ID: 21986253
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
[TBL] [Abstract][Full Text] [Related]
13. [Experience with voriconazole in invasive aspergillosis].
Thiel E; Schwartz S
Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
[TBL] [Abstract][Full Text] [Related]
14. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Kesson AM; Bellemore MC; O'Mara TJ; Ellis DH; Sorrell TC
Clin Infect Dis; 2009 May; 48(9):1257-61. PubMed ID: 19320594
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of voriconazole in a murine model of invasive paecilomycosis.
Rodríguez MM; Pastor FJ; Serena C; Guarro J
Int J Antimicrob Agents; 2010 Apr; 35(4):362-5. PubMed ID: 20129763
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of brain aspergillosis with voriconazole.
Tattevin P; Bruneel F; Lellouche F; de Broucker T; Chevret S; Wolff M; Régnier B
Clin Microbiol Infect; 2004 Oct; 10(10):928-31. PubMed ID: 15373890
[TBL] [Abstract][Full Text] [Related]
18. The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.
Liu W; Sun Y; Chen W; Liu W; Wan Z; Bu D; Li R
Antimicrob Agents Chemother; 2012 May; 56(5):2598-603. PubMed ID: 22314539
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients.
Gené J; Azón-Masoliver A; Guarro J; De Febrer G; Martínez A; Grau C; Ortoneda M; Ballester F
J Clin Microbiol; 2001 Mar; 39(3):1134-6. PubMed ID: 11230441
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Perea S; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2002 Aug; 46(8):2564-8. PubMed ID: 12121933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]